ITEM 2 — UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
−Removed: The following table provides information about share repurchases made by the Company of its common stock during the quarter ended September 30, 2024:
+Added: The following table provides information about share repurchases made by the Company of its common stock during the quarter ended March 31, 2025:
Purchased Weighted
7 unchanged sentences
(in millions) (2)
−Removed: July 1, 2024 — July 31, 2024
+Added: January 1, 2025 — January 31, 2025
— $ — — $ 1,550
−Removed: August 1, 2024 — August 31, 2024
+Added: February 1, 2025 — February 28, 2025
8,125,246 $ 44.40 8,125,246 $ 1,189
−Removed: September 1, 2024 — September 30, 2024
+Added: March 1, 2025 — March 31, 2025
1,961,435 $ 45.37 1,961,435 $ 1,100
2 unchanged sentences
(1) Calculated excluding commissions.
−Removed: (2) In November 2016, our Board of Directors authorized the repurchase of $1.56 billion of its outstanding common stock, which was to expire on November 2, 2018.
−Removed: In June 2018, our Board of Directors authorized increasing the remaining repurchase amount of $1.11 billion to $2.50 billion and extending the expiration date to November 2020.
−Removed: In October 2020, our Board of Directors authorized the extension of the expiration date of the remaining repurchase amount of $916 million to November 2022, and in October 2022, our Board of Directors authorized the further extension of the expiration date of the remaining repurchase amount of $916 million to November 2024.
−Removed: In October 2023, our Board of Directors authorized increasing the remaining share repurchase amount of $916 million to $2.0 billion and extending the expiration date from November 2024 to November 3, 2025.
−Removed: Subsequently, on October 22, 2024, our Board of Directors authorized increasing the remaining share repurchase amount from $195 million to $2.0 billion and extending the share repurchase program’s expiration date to November 3, 2026.
+Added: (2) On October 22, 2024, our Board of Directors authorized increasing the remaining share repurchase amount of the share repurchase program from $195 million to $2.0 billion and extending its expiration date from November 3, 2025 to November 3, 2026.
+Added: Subsequently, on April 22, 2025, our Board of Directors authorized increasing the remaining share repurchase amount from $1.10 billion to $2.0 billion.
All repurchases under the stock repurchase program are made from time to time at our discretion in accordance with applicable federal securities laws.
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.